Signaling pathway cloud regulation for in silico screening and ranking of the potential geroprotective drugs
The major challenges of aging research include absence of the comprehensive set of aging biomarkers, the time it takes to evaluate the effects of various interventions on longevity in humans and the difficulty extrapolating the results from model organisms to humans. To address these challenges we p...
Main Authors: | Alex eZhavoronkov, Anton A. Buzdin, Andrey V Garazha, Nicolas eBorissoff, Alexey A Moskalev |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-03-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fgene.2014.00049/full |
Similar Items
-
Editorial: Should we Treat Aging as a Disease? Academic, pharmaceutical, healthcare policy and pension fund perspectives
by: Alex eZhavoronkov, et al.
Published: (2016-02-01) -
Characteristic patterns of microRNA expression in human bladder cancer
by: Anastasia A. Zabolotneva, et al.
Published: (2013-01-01) -
Screening and personalizing nootropic drugs and cognitive modulator regimens in silico
by: Leslie eJellen, et al.
Published: (2015-02-01) -
A systematic experimental evaluation of microRNA markers of human bladder cancer
by: Anastasia eZabolotneva, et al.
Published: (2013-11-01) -
Friends-Enemies: Endogenous Retroviruses Are Major Transcriptional Regulators of Human DNA
by: Anton A. Buzdin, et al.
Published: (2017-06-01)